Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 16:6:349.
doi: 10.12688/wellcomeopenres.17437.1. eCollection 2021.

Extended Cohort for E-health, Environment and DNA (EXCEED) COVID-19 focus

Affiliations

Extended Cohort for E-health, Environment and DNA (EXCEED) COVID-19 focus

Paul H Lee et al. Wellcome Open Res. .

Abstract

Background: New data collection in established longitudinal population studies provides an opportunity for studying the risk factors and sequelae of the novel coronavirus disease 2019 (COVID-19), plus the indirect impacts of the COVID-19 pandemic on wellbeing. The Extended Cohort for E-health, Environment and DNA (EXCEED) cohort is a population-based cohort (N>11,000), recruited from 2013 in Leicester, Leicestershire and Rutland. EXCEED includes consent for electronic healthcare record (EHR) linkage, spirometry, genomic data, and questionnaire data. Methods: Between May 2020 and July 2021, a new questionnaire was deployed in EXCEED, which captured COVID-19 symptoms, general physical and mental health, plus socioeconomic and environmental factors during the pandemic. An online system was developed to invite new participants to join EXCEED, with informed consent being provided online. New and existing participants then completed the COVID-19 questionnaire online. A subset of the new questionnaire respondents were invited to participate in COVID-19 serology substudies, using home antibody testing kits. Results: In total, 3,693 participants provided COVID-19 infection status (median age 62.9 (IQR 54.7-69.2), 58.9% female). Trends of monthly incidence proportions of COVID-19 in EXCEED (self-report or symptom-predicted) approximated local and national figures. Regression analysis of 2,768 participants with linked EHR data showed no obvious monotonic relationship between number of chronic diseases (of 16 pre-specified diseases) and COVID-19 infection. There were 2,144 participants with valid results from a kit allowing differentiation between antibodies due to vaccination or infection. Of these, 8.5% had results consistent with previous COVID-19 infection, and 85.9% had evidence of COVID-19 vaccination, but without evidence of infection. Conclusions: Enriching EXCEED with a new COVID-19 questionnaire and serology data may improve understanding of the risk factors, clinical sequelae and broader impacts of the COVID-19 pandemic in the general population. Controlled access to these data for bona fide researchers is via application to the EXCEED study.

Keywords: COVID-19; EXCEED; cohort; environment; epidemiology; genetics; longitudinal study; record linkage.

PubMed Disclaimer

Conflict of interest statement

Competing interests: Julian Barwell is a paid consultant to Global Gene Corp and AstraZeneca.

Figures

Figure 1.
Figure 1.. Monthly coronavirus disease 2019 (COVID-19) infection incidence proportions in EXCEED participants predicted by symptom, the UK, and the area of subject recruitment (Leicester, Leicestershire, and Rutland).

References

    1. Marmot M, Allen J: COVID-19: exposing and amplifying inequalities. J Epidemiol Community Health. 2020;74(9):681–2. 10.1136/jech-2020-214720 - DOI - PMC - PubMed
    1. Whitaker M, Elliott J, Chadeau-Hyam M, et al. : Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508,707 people.Imperial College London Preprint. 2021. Reference Source
    1. John C, Reeve NF, Free RC, et al. : Cohort Profile: Extended Cohort for E-health, Environment and DNA (EXCEED). Int J Epidemiol. 2019;48(3):678–9j. 10.1093/ije/dyz073 - DOI - PMC - PubMed
    1. Spitzer RL, Kroenke K, Williams JBW, et al. : A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7. 10.1001/archinte.166.10.1092 - DOI - PubMed
    1. Kroenke K, Spitzer RL, Williams JB: The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13. 10.1046/j.1525-1497.2001.016009606.x - DOI - PMC - PubMed

LinkOut - more resources